What is ValGenesis?
ValGenesis stands as a pioneer in the life sciences industry, having developed the first fully integrated, cloud-based, AI-enabled platform for end-to-end product lifecycle digitalization. Known for its Smart GxP solution, the company provides a unified, risk-based validation and process automation ecosystem. By replacing legacy manual processes with intelligent, connected workflows, ValGenesis enables its clients to streamline operations, enhance compliance, and mitigate operational risks. Currently trusted by 30 of the top 50 global life sciences companies, the firm is instrumental in accelerating the delivery of safer, more consistent products to market, thereby directly impacting global health outcomes.
How much funding has ValGenesis raised?
ValGenesis has raised a total of $40.1M across 3 funding rounds:
Debt
$150K
Private Equity
$24M
Other Financing Round
$16M
Debt (2020): $150K with participation from PPP
Private Equity (2021): $24M led by Morgan Stanley
Other Financing Round (2025): $16M supported by BIG - Banking Innovation Group
Key Investors in ValGenesis
PPP
Public-Private Partnership
Morgan Stanley
A leading global financial services firm providing a wide range of investment banking, securities, wealth management, and investment management services to corporations and institutions.
BIG - Banking Innovation Group
A specialized group focused on future trends, technology, and innovation, providing strategic insights and management consulting to help organizations navigate complex business landscapes.
What's next for ValGenesis?
Following this major enterprise-level funding, ValGenesis is poised to accelerate its product roadmap and expand its footprint in the global life sciences market. The strategic allocation of capital will likely focus on deepening the AI capabilities of the Smart GxP platform and scaling its cloud infrastructure to support increasing demand for automated compliance solutions. As the industry shifts toward fully digitalized, data-driven manufacturing and quality control, ValGenesis is strategically positioned to capture additional market share. The company's focus remains on driving operational excellence for its clients, ensuring that its platform remains the gold standard for validation and lifecycle management in an increasingly complex regulatory environment.
See full ValGenesis company page
